为肝细胞癌武装 GPC3 CAR-T 细胞:多少才足够,下一步是什么?
Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection.
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肝细胞癌(HCC)以低突变负荷和相对较少的TIL(肿瘤浸润淋巴细胞)(TILs)为特征,使得识别特异性治疗的靶点仍然困难。本研究的目的是确定TILs在HCC中的预后作用,重点关注其分布和活化状态。我们回顾性纳入了41例因HCC接受肝切除术的患者。在具有主要实性结构的HCC中观察到CD8+瘤内淋巴细胞显著增加,但PD-1/TIA1比值更高,提示具有实性结构的HCC有更多瘤周淋巴细胞,但功能较低。在多因素和单因素分析中,TIA1/CD8比值与肿瘤复发相关,意味着具有更多活化TILs的HCC以更高的肿瘤侵袭性为特征。使用可行且廉价的免疫组化panel有助于术后预后分层,不仅关注TILs的绝对数量和密度,更应关注其活化状态和形态。
Hepatocellular carcinoma (HCC) is characterized by a low mutation burden and a relatively low number of tumor-infiltrating lymphocytes (TILs), making still difficult to identify targets for specific therapies. The aim of this study was the identification of the prognostic role of TILs in HCC, focusing on their distribution and status of activation.
We retrospectively enrolled 41 patients, undergone to liver resection for HCC. A significant increase of CD8 + intratumoral lymphocytes was observed in HCCs with prevalent solid architecture, but with a higher PD-1/TIA1 ratio, suggesting that HCCs with solid architecture have more peri-tumoral lymphocytes, but with minor functionality.
At multivariate and univariate analyses, TIA1/CD8 ratio correlated with tumor recurrence, meaning that HCC with more activated TILs are characterized by a higher tumor aggressiveness. The use of a feasible and cheap immunohistochemical panel can help in post-surgical prognostic stratification, focusing not only in the raw number and density of TILs, but more on their state of activation and morphology.
MEMBER ACCOUNT
登录成功会直接打开下一页。